BRG1 mutations confer resistance to hormones in lung cancer
30 percent of patients with non-small cells lung cancer present alterations in this gene
2012-03-19
(Press-News.org) Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the characteristics of tumours is that their cells have lost the ability to differentiate; therefore these hormones have useful properties to prevent cancer. Currently, retinoic acid and steroids are being used to treat some types of leukaemia.
A study led by the research group on Genes and Cancer of the Bellvitge Biomedical Research Institute (IDIBELL) has shown that the loss of BRG1 gene implies a lack of response of cells to these hormones, and therefore the tumour may continue growing. Study results have been published in the journal EMBO Molecular Medicine.
BRG1 gene
The IDIBELL research group on Genes and Cancer led by Montse Sanchez-Cespedes discovered some years ago that the BRG1 gene, a tumour suppressor, is inactivated in non-small cell lung cancer by genetic mutations. "The BRG1 protein is part of a chromatin remodelling complex that regulates the expression of several genes", explains the researcher, "and it is related to the differentiation of lung cells, allowing cells response to certain hormones and environment vitamins like vitamin A or steroids."
When BRG1 is mutated and therefore inactive, tumour cells do not respond to the presence of these hormones and they continue growing and spreading. For this reason, these types of tumours are refractory to the treatment with these substances.
Clinic Application
"At the moment", says Montse Sanchez-Cespedes, "we are not able to restore the functionality of a tumour suppressor gene as BRG1 in patients. Therefore, we are still far from a therapeutic application but this discovery enables us to understand better the biology of tumours. What we will try to do in the immediate future is to look for agents that specifically destroy the cells with mutated BRG1, following the strategy of lethal synthetics".
In any case, this finding it can be useful in advancing personalized medicine, because "it explains why lung cancer patients are resistant to these treatments and may serve to rule out therapies with lipid-derived hormones in patients with BRG1 mutations, not just in lung cancer but also in breast and prostate, among others."
INFORMATION:
Article's reference
Romero, O.*, Setien, F.*, John S., Giménez-Xavier P.*, Gómez-López G., Condom E.*, Villanueva A.*, Hager G. and Sánchez-Céspedes M.*. The tumor supressor and chromatin remodeling factor BRG1 antagonizes Myc Activity and promotes cell diferentiation in human cancer. EMBO Molecular Medicine. Doi 10.1002/emmm.201200236.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-03-19
DENVER – A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis. The biomarkers include: prolactin, transthyretin, thrombospondin-1, E-selectin, C-C motif chemokine 5, macrophage migration inhibitory factor, plasminogen activator inhibitor-1, ...
2012-03-19
DENVER – Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy. There are two main approaches, and controversy has existed about which approach is superior. One is called extrapleural pnemonectomy (EPP), a very extensive surgery where surgeons remove the entire diseased lung, lung lining (pleura), part of the membrane covering the heart (pericardium) and part of the diaphragm. Another approach involves a less ...
2012-03-19
DENVER – Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.
As part of a study performed by the Cancer and Leukemia Group B in advanced lung cancer, serum CYFRA levels ...
2012-03-19
Providence, RI--- Winifred Edgerton Merrill (1862-1951) was the first
woman to receive a PhD in mathematics in the United States.
Throughout her life, she worked to advance women in a male-dominated
society. She helped to found Barnard College, the renowned women's
college affiliated with Columbia University, and she founded a college
preparatory school for girls.
As March is National Women's History Month, it is a fitting moment to
look back on the life of this outstanding pioneer. Merrill's
compelling story is told in an article appearing in the April 2012
issue ...
2012-03-19
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
The findings suggest that a relatively simple eye screening could serve as a marker for cognitive changes related to vascular disease, allowing for early diagnosis and treatment, potentially reducing the progression of cognitive impairment to dementia.
As retinopathy usually is caused ...
2012-03-19
In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary.
"It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."
In all likelihood, Darwin's nighttime visitor was a member of Reduviid family of insects — the so-called kissing bugs because of their habit of biting people around the mouth while they sleep.
From this attack, some infectious disease experts have speculated, ...
2012-03-19
Mothers who financially struggle to provide food for their families tend to put themselves at risk for obesity while trying to feed their children, according to Penn State sociologists.
Mothers who do not have enough money to provide adequate food for their families -- food-insecure -- are more likely to be obese or overweight than fathers who face food shortages, as well as food-insecure, childless women and men, said Molly Martin, assistant professor of sociology and demography. Over time, these food-insecure mothers also gain more weight compared to all food-insecure ...
2012-03-19
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
Radiation primarily kills cells by inducing DNA damage, so the aim of the technique is to sensitize cells to radiation by disabling their ability to repair DNA. The technique sneaks RNA molecules into cells that shut down genes needed for DNA repair.
The still-experimental method could potentially allow oncologists to enhance the tumor-killing effects of radiation, while using lower doses and reducing damage to healthy tissues.
In the laboratory, ...
2012-03-19
LOS ANGELES (March 15, 2012) - In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and estrogen plus progestin influence the risk of breast cancer, according to a review published TK in the Journal of The National Cancer Institute.
Although hormone therapy is currently used by millions of women for menopausal symptoms, there is still concern about hormone therapy–induced breast cancer risk. In addition, ...
2012-03-19
Fraser Yachts has a fantastic portfolio of luxury yachts for sale, four of which can be viewed at this year's Antibes Yacht Show (April 12-15th). Fraser Yachts brokers will, of course, be in attendance with M/Y LIVIA, M/Y BEYOND, M/Y VOYAGER and S/Y ALIA 82.
Built in 2009 by the respected Moonen shipyard, the motor yacht LIVIA is a 30m yacht for sale exclusively through Fraser Yachts. Exquisitely appointed throughout she can accommodate up to eight guests and four crew in modern, spacious living quarters. Sail round the Mediterranean this summer at a comfortable 12 ...
LAST 30 PRESS RELEASES:
[Press-News.org] BRG1 mutations confer resistance to hormones in lung cancer
30 percent of patients with non-small cells lung cancer present alterations in this gene
